Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2026Cancer Research

Ganglioside Targeting as a Dual Approach to Neuroblastoma Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

GDGuillermo Nicolás DaltonWKWonju KimKLKevin H. Lu

Discussion

Loading...

Member takes

Overview

This investigation demonstrates improved outcomes using GM2 and GD2 dual targeting in neuroblastoma, suggesting enhanced therapeutic strategies.

Key Points

  • The aim is to understand resistance to anti-GD2 therapy in neuroblastoma and to evaluate GM2 as an alternative immunotherapy target.
  • Conducted murine models for anti-GM2 monoclonal antibodies and CAR T cell therapies.
  • Tested combination therapy with both GD2 and GM2 targeting.
  • Performed tissue distribution analysis of GM2 using immunohistochemistry.
  • Anti-GM2 therapy showed initial efficacy but lacked long-term responses in monotherapy.
  • Combination therapy led to complete tumor eradication and improved survival in murine models.
  • GM2 minimal distribution in normal tissues showed promise for safety in targeting alongside GD2.

Cite This Study

Dalton et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd4ea79560c99a0a33d4https://doi.org/10.1158/1538-7445.am2026-7814
View Full Paper
Ask AI
Bookmark
Share